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Cell migration, chimerism, and graft acceptance 
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The chimeric nature of the transplanted liver was first 
shown in our long-surviving human recipients of orthotopic 
hepatic allografts in 1969.1 When liver grafts were obtained 
from cadaveric donors of the opposite sex, karyotyping 
studies showed that hepatocyteS and endothelium of major 
blood vessels retained their donor specificity, whereas the 
entire macrophage system, including Kuppfer cells, was 
replaced with recipient cells. ~ Where donor cells thathad left 
the liver had gone was unknown, but their continued 
presence was confinned by the acquisition and maintenance 
in recipient blood of new donor-specific immunoglobulin 
(Gm) types1 .3 and red-blood-cell alloantibodies, if donors 
with ABO non-identity were used. 4 Davies et al! attributed 
the secretion of new soluble HLA class I antigens of donor 
type to transplanted hepatocytes. However, these HLA 
molecules come from bone-marrow-derived rnacrophages 
and/or dendritic cells,6 and probably have the same origin 
from migrated donor cells as the additional Gm types and 
red-cel1 antibodies. 
Although this early evidence of systemic mixed allogeneic 
chimerism was circumstantial, we have recently shown with 
both anatomical and molecular techniques the presence, in 
clinically stable patients, of peripherally located donor cells 
many years after liver replacement. For instance, in patients 
with type N glycogen storage disease, a disorder in which an 
insoluble amylopectin-like polysaccharide accumulates 
throughout the body because of a deficiency in a branching 
enzyme, we found resorption of extrahepatic amylopectin 
after liver replacement.7 This process could not be explained 
until the migrated donor cells, which had acted as enzyme 
couriers, were identified by both HLA monoclonal 
antibodies (fig 1) and polymerase chain reaction (peR) 
studies (fig 2) in the biopsied myocardium and skin of 2 
patients, 33 and 91 months after hepatic transplantation. 
Recent experiments in rats have shown the timing and 
extent of seeding from the hepatic allograft to both 
non-lymphoid and lymphoid organs (fig 3).8 A similar 
panern of distribution was found after successful rat-to-
mouse bone-marrow transplantation.9 This similarity 
between liver transplantation and bone-marrow 
transplantation has not been repOrted before. The prompt 
development, and then the persistence, of this systemic 
chimerism may help to explain the resistance of the liver (Q 
celluJar1° and humoralll rejection, as well as its 
tole:rogenicity to other organs from the same donor. U 
The chimeric structure of the transplanted liver was 
thought to be a unique feature of this organ for many years 
until we identified lymphoid and dendritic cell replacement 
under FK 506 immunosuppression in rat13 and human14 
intestinal allografts; a similar finding has been reported in 
swine.15 In our experiments with rats, the: two-way traffic 
was the same, irrespective of whether bowel was 
transplanted alone or as a part of a multivisceral graft that 
also contained liver, stomach, and pancreas.13 Replaced 
donor lymphoid and dendritic cells spread through vascular 
routes to host lymphoid tissues, creating a state of mixed 
allogeneic chimerism-free of lethal or even clinically 
detectable graft-versus-host disease (GVHD) except in 
special strain combinations in which there is a poorly 
understood imbalance between the graft and recipient 
immune systems.16.17 
In addition, GVHD has been only a minor difficulty in 
human beings after cadaveric small bowel or multivisceral 
allotranspIanration,14.18.19 despite the use of 
rustoincompatible donors and the routine development (as 
with the liver) of mixed allogeneic chimerism. Resistance to 
GVHD has also been described with mixed allogeneic or 
xenogeneic chimerism after bone-marrow transplantation. 2D 
This might be explained by responses of coexisting donor 
and recipient immune cells, each to the other, causing 
reciprocal clonal expansion followed by peripheral clonal 
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Fig 1-Heart (upper) and skin (lower) biopsy samples 33 
months aftar liver transplantation. 
Immunoperoxidase stain with monoclonal antibody GSP5.3 that 
reacts with HLA-B7, which was present In the donor and not the 
recipient. Rust-coloured cells (numerous in heart. sparse in skin) are 
from donor (magnification x 500). 
deletion (fig 4). If these or similarl1 events do take place, then 
the deliberate "unbalancing" of the donor-recipient axis by 
cytoreduction (or cytoablation), which is nonnally part of 
bone-marrow transplantation, should be re-examined 
because it restricts acceptable marrow donors (perhaps 
unnecessarily) to those with major histocompatibility 
complex (MHC) concordance. 
The abundance of lymphoreticular cells in the liver and 
intestine, plus the development of phenotyping 
techniques,,·14.z2 have contributed to the discovery of cell 
migration and repopulation that follows organ 
transplantation. We believe that cell migration takes place to 
some degree with all successful transplantations, 
irrespective of the organ. with rapid seeding through the 
blood stream. As far back as 1962-63, we found evidence 
that cells migrated from kidnev allografts into recipients 
treated with azathiopnne and' prednisone!3 After renal 
transplantation, prevlQusly negative tuberculin, 
histoplasmin, and other skm tests among recipients always 
became positive to antigens that had been shown to provoke 
pOSitive reactions In their donors. These results were 
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Fig 2-Chimerism after human liver transplantation, 
Southern blot analysis of polymerase chain reaction (PCR) products 
of liver (L), heart (H), and skin (S) 91 months after liver transplantation 
from HLA- DR1-specific and DRw52-associated amplification of the 
DRB1 gene in tissue biopsy samples. The presence of the donor 
DRB1 *01 01 (donor-specific) allele in all three tissues was confirmed by 
hybridisation to a ORB-specific probe and by oligonucleotide probe 
subtyping of DR1 -specific PCR products. 
M, molecular weight marker; N, PeR-negative control. 
interpreted as showing adoptive transfer of donor cellular 
immunity "by leukocytes in the renal vasculature and hilar 
lymphoid tissue".24 
At the time, alteration of graft antigenicity was suggested 
as an explanation for the reversal of kidney rejection in these 
patients when prednisone was added to baseline therapy 
with azathioprine, and for the ability later to reduce 
maintenance irnrnl.mosuppression.23 More than 28 years 
later, chimerism as a reason for diminished antigenicity was 
demonstrated with immunocytochemical and PCR 
techniques in biopsy samples from the renal allograft, skin, 
and lymph nodes of several of these same patients 
(unpublished observations). Such reductions in antigenicity 
of free thyroid grafts, when located in the anterior chamber 
of the guinea pig eye before subcutaneous engrafunent, had 
been observed by Woodruff and WoodrufP5 who called this 
process "adaptation". 
We have also described cell repopulation of human 
heart-lung allografts from studies of necropsy samples of 
recipients treated with cyclosporin. ~S In untreated rats, Prop 
et al17 showed that a lymphoid-poor heart is less vigorously 
rejected than a lung that contains rich bronchus-associated 
lymphoid tissue (BAL T). However, this order of 
susceptibility to rejection was reversed with postoperative 
cyclosporin, which often induced pennanent acceptance of 
the rat lung, but never of the heart. This paradox was 
explained by the greater volume and ease of migration of the . 
lung's lymphoid and dendritic cell population. Pennanent 
graft acceptance in rats after a brief induction course of FK 
506 has also been shown to be more difficult to achieve with 
the heart than with the liver, ,8 a difference that is reflected by 
the difficulty of maintenance of seeded peripheral donor 
cells after cardiac but not liver engraftment.8 
Thus, cell traffic seems to be a striking event with all 
transplants. Donor cells leaving the solid organ graft and 
recipient cells entering it include passenger leucocytes that 
were shown by Steinmuller29 to be the main cause of 
allograft immunogenicity. These cells are a distinct family of 
bone-marrow derived antlgen presenting dendritic 
leucocytes.3o These dendritic leucocytes are distributed 
throughout the body, including organs once thought to be 
mostly devoid of immunologically active cells.30.31 The 
evidence Implicating these antigen-presentUlg cells in 
primary T-cell alloimmunity2.l.3o.32 has prompted efforts to 
eliminate them before transplantation. 33.3. 
Whether this reduction of graft antigenicity is beneficial 
remains uncertain. Our data show that migration of 
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Fig 3--Result of traffic of donor and recipient Iymphoreticular 
cell traffic after successful liver transplantation. 
White. recipient cells: black. donor celis. 
dendritic and lymphoid cells is associated with graft 
acceptance rather than rejection, depending on the quality of 
immunosuppression, the immunological substrate of the 
organs, donor-recipient histocompatibility, and perhaps 
other factors. The fine margin between graft rejection and 
acceptance was shown by Annstrong et al,35 who found an 
association between the increased rate of dendritic cell 
replacement and the survival of renal allografts transplanted 
to rats after they had been immunised by blood transfusion 
from the donor strain. 
Thus, contrary to the dendritic cell deletion approach, the 
objective perhaps should be to promote, not prevent, 
two-way cell migration while at the same rime giving 
treatment to avoid graft destruction or GVHD, which are 
the nonnal and inevitable consequences of migration. If so, 
improved treatment strategies might include peri operative 
infusion of bone-marrow or other immunocompetent 
cells.31>-3a Antigen extracts or killed cells cannot substitute for 
living cells. 38.39 
We ha.ve not attempted to distinguish between drug-free 
"classical tolerance", as defined by Billingham, Brent, and 
Medawar,36 the tolerance found after bone-marrow 
transplantation, and the ambiguous "graft acceptance" 
referred to by solid organ transplant surgeons. We believe 
that all are variants or~ges of the same cell migration 
process. Clinical success-tolerance or graft acceptance-
means that a characteristic lymphoid and dendritic cell 
chimerism has been introduced, which may be stable either 
without further treatment or only when continued 
immunosuppression is provided; an unstable graft and its 
migrated cells may either be rejected or cause GVHD. 
Thus, our view of solid organ graft acceptance can be related 
easily to the Billingham-Brent-Medawar model of actively 
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Fig 4-Reciprocai clonal expansion and depletion by immune 
cells in graft and recipient. 
HVG: host vs graft. 
acquired tolerance,36.40 and accommodates WoodrufPs 
suggestion about "replacement of certain elements of graft, 
for example connective tissue stroma and vascular 
endothelium" .41 
Medawar was perplexed by the unexpected success of 
clinical renal transplantation and wrote that " ... foreign 
kidneys do sometimes become acceptable to their hosts for a 
reason other than acquired tolerance in a technical sense ... 
One possible explanation is the progressive and perhaps 
very extensive replacement of the vascular endothelium of 
the graft by endothelium of host origin, a process that might 
occur insidiously and imperceptibly during a homograft 
reaction weakened by immunosuppressive drugs". 42 He was 
unaware of the existence of cell migration and its possible 
association with transplant tolerance. 
Since cell migration quickly transforms both the graft and 
the recipient into chimeras, both the importance of HIA 
matching for bone-marrow transplantation (an inherently 
immunologically unbalanced procedure)· and its 
imperfection as a predictor for outcome of solid organ 
transplantation43.... might now have an explanation. 
Although the dynamics of the chimeric state remain 
speculative, the reciprocal clonal deletion that was invoked 
to explain GVHD resistance (fig 4) can be thought of as 
immunosuppressive in proportion to the degree of MHC 
incompatibility. This process would be especially important 
with organs such as the liver and intestine, which have an 
important immunological component. 
Cell migration, which we believe is an invariable early 
event in graft acceptance, could lead to self-perpetuating and 
presumably linked changes in the host immune response, 
which do not depend on th'e continued survival of seeded 
donor cells. Hypotheses such as these have defied attempts 
at verification:s probably because the proposed elements of 
each theory are simply epiphenomena of the key event: cell 
migration and repopulation. 
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From The Lancet 
Medicine and war 
The health of amries and fleets has been for many years 
considered an object of the highest: national importance. 
Commanders by land or sea, who have deserved to be called great, 
have always manifested the utmost solicitude on this point, and, 
however lavish of the blood of their followers on those days of 
struggle that decide the fate of nations, were most careful of their 
health and vigour, and so were enabled to take advantage of the 
moment, and to win their battles. It is said of Wellington that at the 
most critical juncture of his career his thoughts were chiefly 
occupied with his soldiers' shoes; and the heroic Nelson is known to 
have made it his boast that in a small vessel he rornmanded in his 
youth he had not lost a man by sickness. In the war.; of the last 
century, when the military art became more highly organised than 
in the half-feudal times of the Tudors and Stuarts, great attention 
began to be paid to the health aftroops and seamen by their medical 
officers. While Sir J olm Pringle and others were endeavouring to 
save armies in the field, Lind, Trotter, Blane, and other 
distinguished naval men made hygiene or preventive medicine their 
special study, and with more striking results. On board ship, 
sanitary regulations can be applied with greater precision and 
exactitude than anywhere else. Some most interesting experiments 
were made as to the influence of diet, climate, &c, both at home and 
abroad, and the naval medical officers of that time may be justly 
a=unted the founders, in this country at least, of sanitary science. 
Their works are replete WIth instruction, and many useful hints may 
even now be gathered from them. 
(March 2, 1867) 
